STRENGTHENING THE SUPPORT MECHANISM

FOR THE PHILIPPINE DRUG ENFORCEMENT

AGENCY
WHEREAS, by virtue of the Comprehensive Dangerous
Drugs Act of 2002 (Republic Act R.A. No. 9165), the Philippine
Drug Enforcement Agency (PDEA) was created for the efficient
and effective law enforcement of all the provisions on
dangerous drugs and/or precursors and essential chemicals
as provided in R.A. No. 9165;

WHEREAS, pursuant to R.A. No. 9165, the Dangerous Drugs

Board (DDB) is the policy-making and strategy-formulating
body in the planning and formulation of policies and programs
on drug prevention and control.

WHEREAS, R.A. No. 9165 provides for the abolition of the

drug enforcement units of the Philippines National Police (PNP),
the National Bureau of Investigation and Bureau of Customs;

GENERICS ACT OF 1988 (REPUBLIC ACT NO. 6675)

This (RA 6675) Act, consisting of 15 sections, declares the
policy to promote, require and ensure the production of
adequate supply, use and acceptance of drugs (including for
animal use) identified by their generic names. Its’ objectives are:
to promote, encourage, and require the use of generic
terminology in the importation, manufacture, distribution,
marketing, advertising, and promotion, prescription, and
dispensing of drugs; to ensure the adequate supply of drugs
with generic names at the lowest possible.

An act to promote, require, and ensure the production of

an adequate supply, distribution, use, and acceptance of drugs
and medicines identified by their GENERIC NAMES.
 A generic drug is a medication created to be the same as
an existing approved brand-name drug in dosage form, safety,
strength, route of administration, quality, and performance
characteristics.

BOTH BRANDED AND GENERIC DRUGS ARE

IDENTICAL IN TERMS OF:
❖ Content
➢ Generic drugs have the same active ingredient to
their branded counterparts.
❖ Quality
➢ Safety
➢ Efficacy
➢ Purity
➢ Potency

BRANDED DRUGS ARE MORE EXPENSIVE DUE TO:

❖ Patenting Cost
❖ Production Cost
❖ Advertising

WHO SHALL USE GENERIC TERMINOLOGY?

❖ All government health agencies and personnel
❖ All medical, dental, and veterinary practitioners & private
practitioners

DRUG OUTLETS INCLUDING:

1. Drugstores
2. Hospitals / Non-hospital Pharmacies
3. Supermarkets & Stores

Every manufacturing company has a generic coounterpart of

their branded meds.
HOW CAN PHARMACISTS APPLY THE LAW?
1. Provide generics menu card with updated prices. Let the
client choose.

DRUG INFORMATION RESOURCES

❖ The nurse, as well as other health professionals who may
prescribe, dispense, or administer medication, requires
reliable and current drug information. Such a need is
heightened when one considers the constant dynamic
changes in pharmacology. Dozen of new drug products
are released every year and recent years have seen several
drug recalls.
❖ In an institution, the most readily available source of drug
information may be the institution’s drug formulary. This is
a continually revised (usually semi-annually) compilation of
drugs and drug products available for use in an
institution.
❖ Drug Information Handbook
➢ The drug information section of the handbook
lists all drugs alphabetically by generic name
with extensive cross-referencing provided by U.S.
brand names, Canadian brand names, and index
terms.

THE PRODUCT/PACKAGE INSERT

❖ A product insert is a detailed description of a drug
product that is required to be included in the package of
all legal drug products sold in the United States. The
contents of the product insert must be approved by the
FDA before the drug can be marketed. The insert must be
periodically updated to represent the current information
available about the drug.